Pharmacovigilance Training Online
Choose from 4 GPvP Online Modules
Welcome to Whitehall Training - experts in online compliance training
Pharmacovigilance Training (GPvP)
Pharmacovigilance Training
Our Good Pharmacovigilance Practice (GPvP) online training platform allows you to access our courses from wherever you are. Get trained and certified at your convenience.
If you are involved in any aspect of pharmacovigilance (GPvP), our four course modules will help you comply with European & US law. The modules are perfect for you if you are involved in drug safety, pharmacovigilance, regulatory and quality compliance.
Discounts are available for multiple purchases and there is a comprehensive control panel service that enables company training managers to monitor and control groups of students.
Pharmacovigilance Training
| Module | Course Topic | Regulations | Course Language | CPD Points | ||
|---|---|---|---|---|---|---|
| GPvP - 1 | GPvP - Drug Safety | International | English | 4 | ||
| GPvP - 2 | GPvP - Global Regulatory Requirements | International | English | 3 | ||
| GPvP - 3 | GPvP - Audit | International | English | 3 | ||
| GPvP - 4 | GPvP - Signalling & Risk Assessment | International | English | 3 | ||
| GPvP - 1R | GPvP - Drug Safety | International | Russian | 4 | ||
| GPvP - 2R | GPvP - Global Regulatory Requirements | International | Russian | 3 | ||
| GDvP | GDvP - Device Safety & Vigilance | International | English | 4 |
Testimonial
"Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP courses I need for my collaborators and colleagues. The wide variety of translations is particularly helpful for an international company like ThreeWire. The IT department is always available to update the status of the customers’ accounts and to help with any technical issues, which makes Whitehall Training a very reliable partner."Rinaldo Cavallo - Country Manager Italy, Scandinavia and Portugal
Course Author
Mr Steve Jolley is a Cambridge University graduate with over 25 years’ experience in drug safety & pharmacovigilance, who specializes in global safety compliance, business process improvement and signal detection. He is the Chairperson of the DIA Clinical Safety and Pharmacovigilance steering committee for North America and has worked with over 80 clients in the US, Europe and Japan. He is a featured speaker with the FDA and MHRA at DIA conferences and webinars on drug safety topics including auditing and signaling.
What is Pharmacovigilance (Pv)?
Pharmacovigilance monitors the safety of a drug once it has been launched onto the market. It is the process which improves the safety of medicines. It detects medicines that cause serious adverse drug reactions (ADRs) and ensures they are re-evaluated or removed from the market to protect public health.
Why is our course certificate important?
UK inspectors have rights conferred under the Medicines Act 1968 sections 111(1 to 3) and 112 (1 to 4 and 7). These include the right to enter any premises covered by the Act to carry out inspections, and take copies of Pharmacovigilance compliance documentation. In the US, if the FDA is unsatisfied with an inspection, they have powers to seize product, issue sizeable fines and even launch criminal proceedings.
Our course certificate enables you to quickly demonstrate that your staff has undergone the appropriate training and helps show that your company has appropriate pharmacovigilance systems in place.
Who can be inspected?
Depending on location, different legislation governs adverse drug reaction reporting within clinical trials and under post-marketing conditions. For example pharmacovigilance within clinical trials is governed by Directive 2001/20/EC - Volume 10 in the EU, by 21 CFR 312 (IND) in the US and by ICH E2A (Clinical Safety) and ICH E2F (DSUR) globally. But in all cases, the relevant regulatory body can carry out inspections of trials as well as marketing authorisation holders (MAHs) to ensure the correct systems are in place to capture and report adverse drug reactions.